Point72 Asset Management
ACOR

Point72 Asset Management’s Acorda Therapeutics ACOR Stock Holding History

Point72 Asset Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-23,214
Closed -$747K – 1717
2022
Q1 		$747K Hold
23,214
– – ﹤0.01% 992
2021
Q4 		$1.11M Sell
23,214
-194
-0.8% -$13.4K ﹤0.01% 896
2021
Q3 		$2.15M Sell
23,408
-21,037
-47% -$1.75M 0.01% 781
2021
Q2 		$4.24M Sell
44,445
-136
-0.3% -$11.9K 0.02% 633
2021
Q1 		$4.34M Buy
44,581
+37,053
+492% +$4.55M 0.02% 598
2020
Q4 		$623K Sell
7,528
-9,139
-55% -$840K ﹤0.01% 834
2020
Q3 		$1.03M Buy
16,667
+1,065
+7% +$80.3K 0.01% 776
2020
Q2 		$1.38M Buy
15,602
+2,355
+18% +$249K 0.01% 646
2020
Q1 		$1.48M Sell
13,247
-25,836
-66% -$5.09M 0.01% 541
2019
Q4 		$9.57M Buy
39,083
+30,675
+365% +$7.74M 0.05% 384
2019
Q3 		$2.9M Buy
8,408
+4,947
+143% +$2.69M 0.02% 542
2019
Q2 		$3.19M Buy
3,461
+1,443
+72% +$1.77M 0.02% 586
2019
Q1 		$3.22M Buy
+2,018
New +$3.64M 0.01% 635
2016
Q4 		– Sell
-926
Closed -$2.32M – 872
2016
Q3 		$2.32M Buy
926
+296
+47% +$883K 0.02% 543
2016
Q2 		$1.93M Buy
630
+122
+24% +$397K 0.01% 569
2016
Q1 		$1.61M Sell
508
-754
-60% -$3.13M 0.01% 577
2015
Q4 		$6.48M Sell
1,262
-7,761
-86% -$33.9M 0.05% 373
2015
Q3 		$28.7M Buy
+9,023
New +$35M 0.23% 132
2015
Q1 		– Sell
-2,065
Closed -$10.1M – 826
2014
Q4 		$10.1M Buy
+2,065
New +$8.86M 0.07% 326
2014
Q3 		– Sell
-5,130
Closed -$20.8M – 800
2014
Q2 		$20.8M Buy
+5,130
New +$20.9M 0.13% 201

Other funds holding ACOR

DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
CCA
Canyon Capital Advisors Dallas, Texas $772M AUM 32.81% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SC
Saltoro Capital Dallas, Texas $30K AUM 24.79% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Point72 Asset Management's ACOR Position: Q2 2022 in Review

Point72 Asset Management sold out of Acorda Therapeutics (ACOR) in Q2 2022, closing a stake of 23,214 shares — an estimated $747K sold.

Point72 Asset Management first reported a position in ACOR in Q2 2014 and held it in 20 quarters. The position peaked at $28.7M in Q3 2015. 32 funds tracked by Wall St. Rank hold ACOR as of Q2 2022.

  • Point72 Asset Management reported no remaining Acorda Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Point72 Asset Management sold 23,214 Acorda Therapeutics shares in Q2 2022, an estimated $747K.
  • Point72 Asset Management first reported a position in Acorda Therapeutics in Q2 2014 and held it in 20 quarters.
  • Point72 Asset Management's Acorda Therapeutics position peaked at $28.7M in Q3 2015.
  • 32 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2022.

Based on Point72 Asset Management's 13F filing for Q2 2022, filed 15 Aug 2022.